Year: 2018
Type: article
Abstract: Glucagon-like peptide 1 (GLP-1) is likely best known by many readers of Diabetes because of the role it plays in insulin secretion. Indeed, GLP-1 receptor (GLP-1R) agonists have become important tools for glycemic control in the treatment of type 2 diabetes. In addition to its incretin effects, GLP-1 signaling plays a role in the control of feeding (1) and other motivated behaviors such as fluid intake (2) and drug taking (3,4). Although many of the effects of GLP-1 are known to be mediated at least in part by activation of central GLP-1Rs, the source(s) of endogenous GLP-1 that activate these receptors remain unclear. Complicating this issue is the fact that GLP-1 is produced both peripherally in the ileum, from which it is released into circulation, and centrally in limited regions of the brain that include the nucleus of the solitary tract (NTS) and the olfactory bulb (1,5) (Fig. 1).
Figure 1
GLP-1 interactions with the brain. GLP-1–producing cells (yellow circles) are found in areas including the ileum, olfactory bulb, and hindbrain. GLP-1–responsive structures in the brain are far more distributed and include structures behind (blue) and outside of (red) the blood-brain barrier, a subset of which are represented in this schematic. Knowing which source of GLP-1 acts on which of the responsive structures is important in order to understand the …
Source: Diabetes
DOI: 10.2337/dbi18-0045
Institution: University at Buffalo, State University of New York
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: Amylin-mediated control of energy balance in the mesolimbic reward system, How the brain controls food intake: the emerging role of the brain GLP-1 system in energy balance and autonomic control, Neural circuits of glucagon-like peptide-1 (GLP-1) action in health and disease, GLP-1 Effects in Water and Salt Intake
OpenAlex ID: W2906464266
